Carrier Screening Market by Product and Service, Type (Expanded (Customized, Predesigned) Targeted Diseases, Medical condition (Hematologic, Pulmonary), Technology (DNA Sequencing, PCR), End user, Region - Global Forecast to 2028", is expected to reach USD 5.4 billion by 2028 from USD 2.2 billion in 2023, at a CAGR of 19.7% during the forecast period

Market is driven by factors such as High risk of chromosomal abnormalities with advancing maternal age and Increasing number of fertility clinics and IVF centers, as Carrier screening is a genetic testing method designed to identify individuals who carry specific genetic mutations that may be passed on to their offspring. While carrier screening primarily focuses on single gene disorders, chromosomal abnormalities can also be part of the considerations On the other hand, Ethical and Legal Concerns is expected to limit market growth to a certain extent in the coming years. As Genetic information is sensitive and can have implications not only for the individual but also for their family members. Likewise, Integration with Telehealth and Digital Health Platforms and Government initiate and policies are anticipated to propel market growth opportunities as Telehealth eliminates barriers related to geographic distance and transportation, making carrier screening services more accessible to a broader population. Individuals can access genetic counseling and testing services from the comfort of their homes. However, availability of lack of practiced professionals is anticipated to hinder market development.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=72642285

Key Market

The major players in the Carrier Screening Assays Market are

Invitae Corporation.(US) ,
Fulgent Genetics.(US),
Eurofins Scientific (Germany),
OPKO Health, Inc.(US),
Thermo Fisher Scientific Inc.(US),
Quest Diagnostics Incorporated (US),
Myriad Genetics, Inc (US),
Illumina, Inc.(US),
Natera, Inc.(Italy),
Laboratory Corporation of America Holdings.(US),
CENTOGENE N.V.(Germany), and
DiaSorin S.p.A.(Italy)
DRIVER: the increasing prevalence of genetic disorders

The rising prevalence and awareness of genetic diseases contribute significantly to the growth and demand in the carrier screening market. Carrier screening is a crucial tool for identifying individuals who carry a single copy of a gene mutation associated with a specific genetic disorder.

There are an estimated 10,000 different types of single-gene diseases (also called monogenic diseases), which are diseases caused by mutations in a single gene. The World Health Organization estimates that 10 out of every 1000 people are affected. This means that between 70 million and 80 million people in the world are living with one of these diseases. Similarly, as per the NIH, around 350 million people are living with rare disorders, and this is a disorder or condition with fewer than 200,000 people diagnosed. About 80% of these rare disorders are genetic in origin, and 95% of them do not have even one treatment approved by the FDA. In addition, as per a new scientific paper published in the European Journal of Human Genetics has confirmed that the number of people worldwide living with a rare disease is estimated at 300 million.

In addition, the rising prevalence of hereditary cancer is indeed a significant driver for the market. Carrier screening, particularly for cancer susceptibility genes, plays a crucial role in identifying individuals who carry genetic mutations associated with an increased risk of developing certain types of cancer. For instance, as per the NIH, up to 10% of all cancers may cause by inherited genetic changes. As a result, The rising prevalence of genetic diseases underscores the importance of carrier screening as a preventive measure and a tool for informed decision-making in family planning. As awareness continues to grow the market is likely to play an increasingly crucial role in managing and preventing genetic diseases.

Inquiry Before Buying @ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=72642285

Predesigned Panel Testing in Expanded Carrier Screening type segment to witness the highest shares during the forecast period.”

Based on the type, the global Carrier Screening Market Size is segmented into Expanded Carrier Screening (Customized Panel Testing, Predesigned Panel Testing)., and Targeted Diseases Carrier screening. The Predesigned Panel Testing is expected to dominate because of its wider application. Predesigned testing panels are widely used in carrier screening for several reasons, providing benefits in terms of efficiency, cost-effectiveness, and comprehensive coverage of genetic conditions. The selection of genes and genetic variants included in predesigned panels is often based on extensive evidence and scientific research. These panels are designed to target well-established and clinically relevant genetic mutations associated with specific inherited disorders.

US dominates the North American Carrier Screening Industry

Based on the North America region, the Carrier Screening Market Share is divided into US and Canada. US is expected to dominate the Carrier Screening Market. The United States has a highly advanced and sophisticated healthcare infrastructure, including research facilities, laboratories, and healthcare institutions. This infrastructure supports the development, adoption, and implementation of advanced diagnostic screening such as carrier screening. Similarly, The U.S. is a global hub for biomedical research and innovation. The presence of leading research institutions, academic centers, and biotechnology companies fosters a conducive environment for the development and validation of novel diagnostic as well as research assays.

India dominates the Asia Pacific Carrier Screening Assays Industry

The APAC Carrier Screening Market is segmented into Japan, China, India, and Rest of APAC. In 2023, India accounted for the largest share of the Asian Carrier Screening Market. The large share of India can be attributed to the economic growth in the country, there is an increase in the incidence of genetic disorders or a higher prevalence of certain conditions in the Indian population, provides a greater demand for carrier screening services. Likewise, the India has one of the world's largest populations, and a larger population often translates to a higher number of individuals seeking healthcare services, including carrier screening.

Request Free Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=72642285

Recent Developments of Carrier Screening Industry:

In 2022, OPKO Health Acquired ModeX Therapeutics, to gain Proprietary Immunotherapy Technology with a Focus on Oncology and Infectious Diseases
In 2021, DiaSorin acquired Luminex Corporation to expands DiaSorin’s offer in the molecular diagnostic sector gaining access to multiplexing technology, which allows analysis of multiple parameters from a single biological sample within a single run.
About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: +1-888-600-6441

Email: [email protected]